Chando launches anti-ageing essence targeting fatigue-related skin ageing

The Chinese group presented, on 23 April in Shanghai, the seventh generation of its Rejuvenation Repairing Essence at the second China Anti-Fatigue-Aging Tech Forum. The launch comes as recent data indicate that the onset of early signs of skin ageing in China has shifted approximately four years earlier between 2018 and 2023, linked to lifestyles marked by stress and lack of sleep.

The new formula is based on HiMurchaSin^® Ultra Anti-Peptide, a proprietary ingredient developed using AI-assisted computational biology, targeting in particular the protein PGC-1α, which is involved in mitochondrial energy regulation and cellular regeneration. According to the company, this active ingredient is intended to support cellular energy production, collagen renewal and improved skin firmness.

Presented as an evolution of its fatigue-related anti-ageing essence, the formula also incorporates L-ergothioneine and probiotic extracts. Chando states that user tests conducted with a third-party organisation, SGS, show visible improvements in skin radiance and wrinkles after several weeks of use, with a claim of up to five years younger-looking skin in eight weeks.

The group highlights its reliance on in-house research and development and proprietary ingredient engineering to optimise performance, costs and product accessibility in the Chinese market.